Basic aspects of psychodermatology

Psychiatria Danubina

Volumn 20, Issue 3, 2008, Pages 415-418

  Buljan, Danijel ^a   Buljan, Marija ^a   Živković, Maja Vurnek ^a   Šitum, Mirna ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Dermatology; Laiason psychiatry; Psychocutaneous medicine; Psychodermatology; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; CLOZAPINE; CORTICOSTEROID; DOXEPIN; HALOPERIDOL; ISOTRETINOIN; LITHIUM SALT; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; STEROID; TRICYCLIC ANTIDEPRESSANT AGENT;

ACNE; AKATHISIA; COGNITIVE THERAPY; CONFERENCE PAPER; DELUSION; DEPRESSION; DERMATOLOGY; DISEASE EXACERBATION; DRUG ERUPTION; DRY EYE; DYSTONIA; EMOTIONAL STRESS; EXTRAPYRAMIDAL SYNDROME; HAIR LOSS; HUMAN; HYPNOSIS; HYPOMANIA; LUPUS VULGARIS; MENTAL DISEASE; MUSCLE STIFFNESS; PARKINSONISM; PHOTOSENSITIVITY; PHOTOSENSITIZATION; PRURITUS; PSORIASIS; PSYCHOCUTANEOUS DISEASE; PSYCHOLOGY; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; RELAXATION TRAINING; RESTLESS LEGS SYNDROME; SIDE EFFECT; SKIN DISEASE; STRESS MANAGEMENT; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYMPTOM; TARDIVE DYSKINESIA; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; XEROSTOMIA;

COGNITIVE THERAPY; DERMATOLOGY; HUMANS; MENTAL DISORDERS; PATIENT CARE TEAM; PSYCHIATRY; PSYCHOPHYSIOLOGIC DISORDERS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; REFERRAL AND CONSULTATION; SKIN DISEASES;

EID: 54349097502     PISSN: 03535053     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Koo JY. Psychodermatology: a practical manual for clinitians. Cur Prob Dermato1199 5; 204-32.
2. Prosperi A, Micallef J, Blin O. The use of psychotropic drug sin dermatology. Ann Dermatol Venereol 2002;129:446-9.
3. Koo YM. The use of psychotropic medications in clinical dermatology. Dermatol Clin 1992;10:641-5.
4. Wessely SC, Lewis GH. The classification of psychiatric morbidity in attendees at a dermatology clinic. Br J Psychiatry 1998;155:686-91.
5. Picardi A, Abeni D, Melchi CF, Puddu P, Pasquini P. Psychiatric morbidity in dermatological uotpatients: an issue to be recognized. Br J Dermatol 2000;143:983-91.
6. Koo J, Lebwohl A. Psychodermatology: The Mind and Skin Connection. Am Family Phys 2001;11:1873-8.
7. Koo JYM, Lee CS. General approach to evaluating psychodermatological disorders. In: Koo JYM, Lee CS, eds. Psychocutaneous Medicine. New York, NY: Marcel Dekker, Inc. 2003. 1-29.
8. Amit Garg M, Chren M, and Sands L. et al. Psychological stress perturbs epidermal barrier homeostasis. Arch Dermatol. 2001. 137:53-59.
9. Jafferany M. Psychodermatology: A Guide to Understanding Common Psychocutaneous Disorders. Prim Care Companion J Clin Psychiatry. 2007; 9(3): 203-213.
10. Gupta MA, Gupta AK, and Ellis CN. et al. Some psychosomatic aspects of psoriasis. Adv Dermatol. 1990. 5:21-30.
11. Gupta MA, Schork NJ, and Gupta AK. et al. Suicidal ideation in psoriasis. Int J Dermatol. 1993. 32:188-190.
12. American Psychiatric Association. Diagnostic and Statistical Manuall of Mental Disorders, 4th ed. (DSM-IV). American Psychiatric Association: Washington DC; 1994.
13. Jacobs DG, Deutch NL, Brewer M. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001; 45: S168-S175.
14. Cotterill JA, Cunliffe WJ. Suicide in dermatological ptients. Br J Dermatol 1997;137:246-50.
15. Editorial. Selective serotonin reuptake inhibitors in obsessive/ compulsive disorder. Drugs Ther Bull 1995;33:47-48.
16. Koo J, Gamba C, Psychopharmacology for dermatological patients. Dermatol Clin 1996;14:509-25.